A Phase III, Double Blind, Randomised, Placebo Controlled Study To Assess The Efficacy And Safety Of A Single Treatment Of Clostridium Botulinum Toxin Type A To Improve The Appearance Of Moderate To Severe Glabellar Lines
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008361/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study was to demonstrate the safety and the efficacy of a single
treatment of an injectable liquid form of Clostridium botulinum toxin type A haemagglutinin
complex (BTX-A-HAC; hereafter referred to as BTX-A-HAC Next Generation (BTX-A-HAC NG)), used
for the improvement in the appearance of moderate to severe glabellar lines (the lines
between the eyebrows).
提供机构：
Vivli
创建时间：
2022-08-16
